Trial Profile
A study on efficacy and safety of telbivudine in interruption of intrauterine infection of hepatitis B virus.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2012
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 04 Feb 2010 New trial record